Australia markets closed

CytoDyn Inc. (CYDY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1550+0.0042 (+2.75%)
At close: 03:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/05/2023
31/05/2022
31/05/2021
31/05/2020
Total revenue
0
0
266
0
0
Cost of revenue
0
20,633
73,543
0
0
Gross profit
0
-20,633
-73,277
0
0
Operating expenses
Research development
4,624
2,632
27,043
53,403
52,640
Selling general and administrative
10,545
17,136
44,303
34,320
19,973
Total operating expenses
15,204
19,943
72,127
89,520
74,647
Operating income or loss
-15,204
-40,576
-145,404
-89,520
-74,647
Interest expense
6,045
6,750
15,066
61,031
32,412
Total other income/expenses net
-7,005
-8,750
-3,853
-25,704
-32,042
Income before tax
-51,690
-79,824
-210,820
-176,465
-139,936
Income tax expense
0
0
0
0
0
Income from continuing operations
-51,690
-79,824
-210,820
-176,465
-139,936
Net income
-51,690
-79,824
-210,820
-176,465
-139,936
Net income available to common shareholders
-53,174
-86,736
-212,448
-178,152
-140,644
Basic EPS
-0.08
-0.10
-0.31
-0.30
-0.33
Diluted EPS
-0.08
-0.10
-0.31
-0.30
-0.33
Basic average shares
870,461
836,528
676,900
587,590
421,078
Diluted average shares
870,461
836,528
676,900
587,590
421,078